ClinicalTrials.gg
CompletedNCT06550284Updated Nov 19, 2026

Small Nerve Fiber Activity in Patients With Carpal Tunnel Syndrome Assessed Via Quantitative Sensory Testing

An interventional study of Physical Therapy in Carpal Tunnel Syndrome, sponsored by Brooke Army Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Brooke Army Medical Center · Not applicable, Interventional, and Treatment

How we know

Updated Nov 19, 2026Now CompletedStart date moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
6
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 97 studies in Carpal Tunnel Syndrome with a site in United States — 10 open to participants now, 12 under way, none of them phase 3. Carpal Tunnel Syndrome · United States.

Enrollment
68th of 72
6 · median 50
Started
2024
with 3 others
No phase
47 of 97
7 open now
Registered
90th of 97
by date

Among the 97 studies in Carpal Tunnel Syndrome with a site in United States, this one is the 68th largest by enrollment of the 72 interventional ones that give a count, is one of 4 that started in 2024, is one of 47 with no phase, and was the 90th registered.

Carpal Tunnel Syndrome

590 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.

Browse Carpal Tunnel Syndrome studies →

Open to participants now

10 of the 97 studies in Carpal Tunnel Syndrome with a site in United States are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 72 Carpal Tunnel Syndrome studies recruiting now, 27 (38%) set no upper age limit and 36 (50%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 97 studies in Carpal Tunnel Syndrome with a site in United States, or all of them as a file.
02

Study summary

The diagnosis of carpal tunnel syndrome (CTS) is typically based on clinical findings and confirmatory electrodiagnostic testing. However, electrodiagnostic testing can only assess large A-alpha and A-beta nerve fibers. Quantitative sensory testing (QST) is a series of tests used to assess small nerve fiber changes in the A-delta, c-fibers, and A-beta nerve fibers as well. Previous studies have used QST to assess small nerve fiber changes related to carpal tunnel syndrome and found changes compared to controls. This study will utilize a course of standard physical therapy care and assess for any changes to small nerve fiber activity and how those changes may or may not relate to patient outcomes.

Read the detailed description

Purpose: To assess changes in A-beta, A-delta, and C-fiber function after standard physical therapy interventions in individuals with CTS.

Specific Aim 1 (primary aim): Determine if A-beta, A-delta, and C-fiber functions change following a course of Physical Therapy (PT) in individuals with CTS.

Specific Aim 2 (secondary aim): Describe the relationship between changes in QST and changes in a patient-reported outcome measure after a course of PT in individuals with a clinical diagnosis of CTS.

03

Conditions studied

  • Carpal Tunnel Syndrome

Keywords

  • carpal tunnel syndrome
  • quantitative sensory testing
  • median nerve
  • neuropathy
  • small nerve fiber
04

Who can participate

The criteria were revised on the registry on Nov 19, 2026. See what changed

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

DEERS eligible Age 18-65 Pain and paresthesia in the median nerve distribution A positive Phalen test A positive Tinel test over the carpal tunnel Monofilament threshold > 2.83 (0.07g) over the median nerve distribution Willing to attend physical therapy

Exclusion criteria

Exclusion Criteria:

Nerve root signs consistent with a radiculopathy Suspected radial and ulnar nerve involvement based on monofilament testing Systemic conditions affecting nerve health (e.g. endocrine disorders, diabetes mellitus, rheumatoid arthritis) Previous hand surgery Injections in the upper quarter in the last 6 months Cervical, shoulder, or UE trauma in the last 6 months Currently pregnant or postpartum within the last 6 months No more than minimal care (evaluation and patient education, 1 visit) for the current episode

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
6 participants (actual)

Study arms

  • Experimental
    Carpal Tunnel Syndrome

    Age 18-65 years with unilateral carpal tunnel syndrome.

    Other: Physical Therapy

Interventions

  • OtherPhysical Therapy

    The intervention will be physical therapy standard care.

06

What researchers measure

Primary outcomes

  1. Quantitative Sensory Testing (QST)

    QST is a test method that measures sensory thresholds for temperature sensations, touch, vibration, and pain and is described in section 10.1. All thermal testing (CDT, WDT, CPT, and HPT) will be performed via the TSA 2 Thermosensory Stimulator.

    Time frame: From enrollment until the end of the study at 12 weeks

Secondary outcomes

  1. Boston Carpal Tunnel Questionnaire (BCTQ)

    The BCTQ is a self-based outcome scale measured with 2-parts, the symptom severity scale and functional status scale. Both scales are likert scales 1-5.

    Time frame: From enrollment until the end of the study at 12 weeks

  2. Numeric Pain Rating Scale (NPRS)

    he NPRS is an 11-point scale ('0' indicating no pain, and '10' worst imaginable pain) that will be used to assess pain intensity. This will be measured as the mean of three pain ratings: best pain rating over 24 hours, worst pain rating over 24 hours, and current pain rating.

    Time frame: From enrollment until the end of the study at 12 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided — Requests for deidentified data will be considered on a case by case basis.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Jul 2025, 8 months.

Of 252 non-industry interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 27. This study's 8 months is below that.

Counting every sponsor, half of 262 studies reached it within 12 months; a quarter within 7 and three quarters within 26.

Start moved once since we started tracking on Sep 25, 2026: Nov 2024 → Oct 2024, on Nov 19, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 9, 2024
First posted
Aug 13, 2024
StartActual
Oct 12, 2024was Nov 2024
Primary completionActual
Jul 1, 2025
CompletionActual
Jul 1, 2025
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 19, 2026
Start date
Nov 12, 2024→Oct 12, 2024
Nov 19, 2026
Enrollment
48 (estimated)→6 (actual)
Nov 19, 2026
Eligibility
1 inclusion criterion edited; 1 exclusion criterion edited
What changed in the criteria
Inclusion criteria
  • EditedDEERS eligible Age 18-65 Pain and paresthesia in the median nerve distribution A positive Phalen test A positive Tinel test over the carpal tunnel Monofilament threshold > 2.83 (0.07g) over the median nerve distribution Willing to attend physical therapy
Exclusion criteria
  • EditedNerve root signs consistent with a radiculopathy Suspected radial and ulnar nerve involvement based on monofilament testing Bilateral CTSSystemic conditions affecting nerve health (e.g. endocrine disorders, diabetes mellitus, rheumatoid arthritis) Previous hand surgery Injections in the upper quarter in the last 6 months Cervical, shoulder, or UE trauma in the last 6 months Currently pregnant or postpartum within the last 6 months No more than minimal care (evaluation and patient education, 1 visit) for the current episode
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Recruiting→Completed
    Start date Nov 12, 2024→Oct 12, 2024
    Enrollment 48 (estimated)→6 (actual)
    Eligibility 1 inclusion criterion edited; 1 exclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • EditedDEERS eligible Age 18-65 Pain and paresthesia in the median nerve distribution A positive Phalen test A positive Tinel test over the carpal tunnel Monofilament threshold > 2.83 (0.07g) over the median nerve distribution Willing to attend physical therapy
    Exclusion criteria
    • EditedNerve root signs consistent with a radiculopathy Suspected radial and ulnar nerve involvement based on monofilament testing Bilateral CTSSystemic conditions affecting nerve health (e.g. endocrine disorders, diabetes mellitus, rheumatoid arthritis) Previous hand surgery Injections in the upper quarter in the last 6 months Cervical, shoulder, or UE trauma in the last 6 months Currently pregnant or postpartum within the last 6 months No more than minimal care (evaluation and patient education, 1 visit) for the current episode
    + 5 other changes: identifiers, oversight details, description, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06550284
Lead sponsor
Brooke Army Medical Center
Responsible party
Cortney Shewmaker (Orthopedic Manual Physical Therapy Fellow, Brooke Army Medical Center) — Principal investigator
First posted
Aug 13, 2024
Start date
Oct 12, 2024
Primary completion
Jul 1, 2025
Completion
Jul 1, 2025
Last update
Nov 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion